Pancreatic Neuroendocrine Tumors from Medscape Education Oncology

06/29/2012 - 06/29/2013

Jonathan R. Strosberg, MD
CME Released 6/29/2012, Valid for credit through 6/29/2013

This activity is intended for oncologists, hepatologists, gastroenterologists, radiation oncologists, surgical oncologists, pathologists, and other clinicians involved in the treatment of patients with gastrointestinal (GI) cancer.

The goal of this activity is to disseminate and analyze new data about GI cancer from the Chicago annual meeting so that clinicians involved in caring for patients with GI cancer will be able to assess the near- or long-term applicability of these data to their practice.

Upon completion of this activity, participants will be able to:

Analyze treatment strategies for GI cancers, including the relevance of molecular markers in selecting treatment and targeted therapies, and assess how they might affect current practice

Click here for more information.

Jonathan Strosberg, MD on Pancreatice Neuroendocrine Tumors

Print Friendly, PDF & Email